These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32591907)
21. Anti-VEGFR therapy is one of the healing inhibitors of antiresorptive-related osteonecrosis of the jaw. Kanno C; Kaneko T; Endo M; Kitabatake T; Sakuma T; Kanaya Y; Watanabe Y; Hasegawa H J Bone Miner Metab; 2021 May; 39(3):423-429. PubMed ID: 33196901 [TBL] [Abstract][Full Text] [Related]
22. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw. Ruggiero SL Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329 [TBL] [Abstract][Full Text] [Related]
23. Synchronous antiresorptive osteonecrosis of the jaws and breast cancer metastasis. Flores IL; dos Santos-Silva AR; Della Coletta R; Vargas PA; Lopes MA Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):e264-8. PubMed ID: 24528798 [TBL] [Abstract][Full Text] [Related]
24. Clinical risk factors for severity and prognosis of antiresorptive agent-related osteonecrosis of the jaw: a retrospective observational study. Nashi M; Hirai T; Iwamoto T; Takenobu T J Bone Miner Metab; 2022 Nov; 40(6):1014-1020. PubMed ID: 36166107 [TBL] [Abstract][Full Text] [Related]
25. Response to Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS". Anastasilakis AD; Pepe J; Napoli N; Palermo A; Magopoulos C; Khan AA; Zillikens MC; Body JJ J Clin Endocrinol Metab; 2022 May; 107(6):e2651-e2652. PubMed ID: 35213729 [No Abstract] [Full Text] [Related]
26. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review. Khominsky A; Lim M Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095 [TBL] [Abstract][Full Text] [Related]
27. Development of Antiresorptive Agent-Related Osteonecrosis of the Jaw After Dental Implant Removal: A Case Report. Yamamoto S; Maeda K; Kouchi I; Hirai Y; Taniike N; Yamashita D; Imai Y; Takenobu T J Oral Implantol; 2018 Oct; 44(5):359-364. PubMed ID: 29870295 [TBL] [Abstract][Full Text] [Related]
28. Letter to the Editor From Taguchi: "Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS". Taguchi A J Clin Endocrinol Metab; 2022 May; 107(6):e2646. PubMed ID: 35213697 [No Abstract] [Full Text] [Related]
29. Involvement of Impaired Angiogenesis and Myelosuppression in Antiresorptive-agent Related Osteonecrosis of the Jaw Mouse Model. Igarashi H; Nishizawa S; Miyamoto T; Hikita A; Hoshi K Tokai J Exp Clin Med; 2023 Apr; 48(1):22-31. PubMed ID: 36999390 [TBL] [Abstract][Full Text] [Related]
30. Effect of bisphosphonates on healing of tooth extraction wounds in infectious osteomyelitis of the jaw. Yamashita J; Sawa N; Sawa Y; Miyazono S Bone; 2021 Feb; 143():115611. PubMed ID: 32829042 [TBL] [Abstract][Full Text] [Related]
31. Effectiveness of surgery and hyperbaric oxygen for antiresorptive agent-related osteonecrosis of the jaw: A subgroup analysis by disease stage. Watanabe T; Asai K; Fukuhara S; Uozumi R; Bessho K PLoS One; 2021; 16(1):e0244859. PubMed ID: 33395446 [TBL] [Abstract][Full Text] [Related]
32. The Frequency of Medication-related Osteonecrosis of the Jaw and its Associated Risk Factors. Dodson TB Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):509-16. PubMed ID: 26362367 [TBL] [Abstract][Full Text] [Related]
33. Antiresorptive drug-related osteonecrosis of the jaws, literature review and 5 years of experience. Bernardi S; Di Girolamo M; Necozione S; Continenza MA; Cutilli T Musculoskelet Surg; 2019 Apr; 103(1):47-53. PubMed ID: 29948937 [TBL] [Abstract][Full Text] [Related]
34. Primary wound closure after tooth extraction for prevention of medication-related osteonecrosis of the jaw in patients under denosumab. Matsumoto A; Sasaki M; Schmelzeisen R; Oyama Y; Mori Y; Voss PJ Clin Oral Investig; 2017 Jan; 21(1):127-134. PubMed ID: 26924135 [TBL] [Abstract][Full Text] [Related]
35. Incongruities in the AAOMS position paper: medication-related osteonecrosis of the jaw--2014 update. Chang JI; Hazboun RC; Chang TI J Oral Maxillofac Surg; 2014 Dec; 72(12):2381. PubMed ID: 25315315 [No Abstract] [Full Text] [Related]
36. Multiple osteonecrosis of the jaw, oral bisphosphonate therapy and refractory rheumatoid arthritis (Pathological fracture associated with ONJ and BP use for osteoporosis). Grana J; Mahia IV; Meizoso MO; Vazquez T Clin Exp Rheumatol; 2008; 26(2):384-5. PubMed ID: 18565271 [No Abstract] [Full Text] [Related]
37. Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents. Rodriguez-Lozano FJ; Oñate-Sánchez RE Med Oral Patol Oral Cir Bucal; 2016 Sep; 21(5):e595-600. PubMed ID: 27475683 [TBL] [Abstract][Full Text] [Related]
38. Nonexposed antiresorptive agent-related osteomyelitis of the jaw: a single-center cohort study. Watanabe T; Yoshida T; Akizuki S; Yamanaka S; Nakao K; Fukuhara S; Asai K; Uozumi R; Bessho K J Bone Miner Metab; 2022 Jul; 40(4):657-662. PubMed ID: 35534635 [TBL] [Abstract][Full Text] [Related]
39. Bisphosphonate treatment as a cause of jaw osteonecrosis. Kanat O; Ozet A; Ataergin S; Kuzhan O; Arpaci F; Ozturk B; Komurcu S; Ozturk M Oral Dis; 2007 May; 13(3):346-7. PubMed ID: 17448221 [No Abstract] [Full Text] [Related]
40. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update and CTX. Schwartz HC J Oral Maxillofac Surg; 2015 Mar; 73(3):377. PubMed ID: 25683041 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]